Terms: = Lymphoma AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
125 results:
1. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Shirouchi Y; Nishimura N; Mishima Y; Ishihara Y; Asai H; Tamba M; Hirano M; Hirano K; Teramoto Y; Yoshida K; Takeuchi K; Terauchi T; Maruyama D
Sci Rep; 2023 Aug; 13(1):13713. PubMed ID: 37608029
[TBL] [Abstract] [Full Text] [Related]
3. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.
Choi I; Okada M; Ito T
Ann Hematol; 2023 May; 102(5):1149-1158. PubMed ID: 36995403
[TBL] [Abstract] [Full Text] [Related]
4. Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling.
Shah K; Al Ashiri L; Nasimian A; Ahmed M; Kazi JU
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902436
[TBL] [Abstract] [Full Text] [Related]
5. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
Mitobe Y; Matsuda KI; Sonoda Y
Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
7. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
8. End-of-Life Care for Older Adults with Aggressive Non-Hodgkin lymphoma.
Johnson PC; Markovitz NH; Yi A; Newcomb RA; Amonoo HL; Nelson AM; Reynolds MJ; Rice J; Lavoie MW; Odejide OO; Nipp RD; El-Jawahri A
J Palliat Med; 2022 May; 25(5):728-733. PubMed ID: 34724798
[No Abstract] [Full Text] [Related]
9. Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.
Nozaki K; Sugahara H; Ueda S; Ishikawa J; Karasuno T; Iida M; Kamae T; Moriyama Y; Kawakami M; Kosugi S; Nakagawa M; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
Int J Hematol; 2021 Aug; 114(2):217-221. PubMed ID: 33847924
[TBL] [Abstract] [Full Text] [Related]
10. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.
Yonekura K; Kusumoto S; Choi I; Nakano N; Ito A; Suehiro Y; Imaizumi Y; Yoshimitsu M; Nosaka K; Ohtsuka E; Hidaka M; Jo T; Sasaki H; Moriuchi Y; Ogata M; Tatetsu H; Ishitsuka K; Miyazaki Y; Ueda R; Utsunomiya A; Ishida T
Blood Adv; 2020 Oct; 4(20):5133-5145. PubMed ID: 33091125
[TBL] [Abstract] [Full Text] [Related]
11. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
Giza A; Gałązka K; Jońca M; Raźny M; Zimowska-Curyło D; Wilk M; Goldman-Mazur S; Piątkowska-Jakubas B; Sacha T
J Dermatolog Treat; 2022 Aug; 33(5):2674-2676. PubMed ID: 32924664
[TBL] [Abstract] [Full Text] [Related]
12. Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data.
Matsuda S; Suzuki R; Takahashi T; Suehiro Y; Tomita N; Izutsu K; Fukuhara N; Imaizumi Y; Shimada K; Nakazato T; Yoshida I; Miyazaki K; Yamaguchi M; Suzumiya J
Int J Hematol; 2020 Dec; 112(6):807-816. PubMed ID: 32880824
[TBL] [Abstract] [Full Text] [Related]
13. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract] [Full Text] [Related]
14. Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia.
Moriguchi M; Koh H; Hayashi T; Okamura H; Nanno S; Nakashima Y; Nakane T; Imoto W; Yamada K; Kakeya H; Hino M; Nakamae H
J Infect Chemother; 2020 Oct; 26(10):1054-1057. PubMed ID: 32505444
[TBL] [Abstract] [Full Text] [Related]
15. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.
Nozaki K; Sugahara H; Ueda S; Ishikawa J; Fuji S; Masaie H; Tada Y; Karasuno T; Iida M; Mitsui H; Kamae T; Saito N; Moriyama Y; Kawakami M; Kato R; Nakae Y; Kida T; Kosugi S; Nakagawa M; Uchida Y; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
Leuk Lymphoma; 2020 Sep; 61(9):2113-2121. PubMed ID: 32366194
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and Fludarabine.
Podichetty JT; Brinda BJ; Nelson RP; Karr AH; Prasad NK; Quinney S; Foxworthy Scott S; Kiel PJ
Pharmacotherapy; 2020 Jan; 40(1):26-32. PubMed ID: 31742732
[TBL] [Abstract] [Full Text] [Related]
17. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
18. [Spontaneous Tumor Lysis Syndrome in a Patient with Testicular Malignant lymphoma : A Case Report].
Ichikawa K; Momose H; Mizobuchi SI; Itami Y; Nakahama T; Matsumoto Y; Nakamura T
Hinyokika Kiyo; 2019 Feb; 65(2):49-53. PubMed ID: 31067843
[TBL] [Abstract] [Full Text] [Related]
19. [Metachronous Development of Mantle Cell lymphoma during Active Surveillance in a Patient with Stage I Testicular Cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma.
Zhong H; Chen J; Cheng S; Chen S; Shen R; Shi Q; Xu P; Huang H; Zhang M; Wang L; Wu D; Zhao W
EBioMedicine; 2019 Mar; 41():167-174. PubMed ID: 30827933
[TBL] [Abstract] [Full Text] [Related]
[Next]
